169 related articles for article (PubMed ID: 29446764)
1. Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease.
Zhang S; Luo J; Wu Z; Roggenbuck D; Schierack P; Reinhold D; Li J; Zeng X; Zhang F; Qian J; Li Y
Clin Transl Gastroenterol; 2018 Feb; 9(2):e133. PubMed ID: 29446764
[TBL] [Abstract][Full Text] [Related]
2. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of anti-
Cheng L; Li L; Liu C; Yan S; Li Y
BMJ Open; 2020 Oct; 10(10):e033880. PubMed ID: 33028542
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease.
Zhang S; Wu Z; Luo J; Ding X; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Medicine (Baltimore); 2015 Oct; 94(42):e1654. PubMed ID: 26496271
[TBL] [Abstract][Full Text] [Related]
5. Enterogenous Microbiotic Markers in the Differential Diagnosis of Crohn's Disease and Intestinal Tuberculosis.
Jiang M; Zeng Z; Chen K; Dang Y; Li L; Ma C; Cheng R; Hu K; Li X; Zhang H
Front Immunol; 2022; 13():820891. PubMed ID: 35371004
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
Kim YS; Kim YH; Kim WH; Kim JS; Park YS; Yang SK; Ye BD; Jang BI; Jung SA; Jeen YT; Cheon JH; Choi YS; Choi JH; Kim BJ; Choi CH; Han DS
Clin Chim Acta; 2011 Aug; 412(17-18):1527-32. PubMed ID: 21575618
[TBL] [Abstract][Full Text] [Related]
7. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
[TBL] [Abstract][Full Text] [Related]
8. Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.
Degenhardt F; Dirmeier A; Lopez R; Lang S; Kunst C; Roggenbuck D; Reinhold D; Szymczak S; Rogler G; Klebl F; Franke A; Rieder F
Inflamm Bowel Dis; 2016 Nov; 22(11):2648-2657. PubMed ID: 27753692
[TBL] [Abstract][Full Text] [Related]
9. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
10. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome.
Fresko I; Ugurlu S; Ozbakir F; Celik A; Yurdakul S; Hamuryudan V; Yazici H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S67-70. PubMed ID: 16273768
[TBL] [Abstract][Full Text] [Related]
11. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae antibodies in Behçet's disease--a familial study.
Monselise A; Weinberger A; Monselise Y; Fraser A; Sulkes J; Krause I
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S87-90. PubMed ID: 17067434
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.
Bogdanos DP; Roggenbuck D; Reinhold D; Wex T; Pavlidis P; von Arnim U; Malfertheiner P; Forbes A; Conrad K; Laass MW
BMC Gastroenterol; 2012 Aug; 12():102. PubMed ID: 22866900
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease.
Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR
Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988
[TBL] [Abstract][Full Text] [Related]
16. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
17. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.
Ng SC; Hirai HW; Tsoi KK; Wong SH; Chan FK; Sung JJ; Wu JC
J Gastroenterol Hepatol; 2014 Sep; 29(9):1664-70. PubMed ID: 24910240
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
[TBL] [Abstract][Full Text] [Related]
19. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.
Wang ZZ; Shi K; Peng J
Biomed Rep; 2017 Apr; 6(4):401-410. PubMed ID: 28413638
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
